Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin

This study has been completed.

Sponsor:

Information provided by:

Emisphere Technologies, Inc.

ClinicalTrials.gov Identifier:

NCT01312831

First received: March 4, 2011

Last updated: March 9, 2011

Last verified: March 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	December 2010
Estimated Primary Completion Date:	No date given

No publications provided by Emisphere Technologies, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Castelli MC, Friedman K, Sherry J, Brazzillo K, Genoble L, Bhargava P, Riley MG. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study. Clin Ther. 2011 Mar;33(3):358-371.e2.

To Top